Mutations affecting the paracellular Mg2+transport pathway in the TAL (CLDN16, CLDN19, RRAGD, CASR)results in the hypomagnesemia with hypercalciuria and nephrocalcinosis[79]. The gene discussed is CLDN16; the disease is nephrocalcinosis.